This page is intended for UK healthcare professionals only. Prescribing information and adverse event reporting can be found at the bottom of this page.
Watch again webinars
The content for this page is currently in development. To be notified when it becomes available, please complete the form below.
Please select your preferences below by checking the appropriate boxes- select all that apply. By signing up, you consent to receive general email updates regarding CarbonNil Medical.
"*" indicates required fields
You can change your preferences or unsubscribe at any time by emailing info@carbonnilmedical.co.uk
CLICK HERE for Sibnayal® (potassium citrate/potassium hydrogen carbonate) prescribing information
Adverse event reporting: Reporting suspected adverse reactions after authorisation of the medicinal product is important. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Advicenne@vigipharm.fr. Information about this product, including adverse reactions, precautions, contraindications, and method of administration can be found in the full SmPC. For a copy of the SmPC or further information please contact Advicenne@vigipharm.fr
PP/CNM/2026/021 January 2026